Page last updated: 2024-08-26

ici 164384 and san 58035

ici 164384 has been researched along with san 58035 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balaguer, P; Boubekeur, N; de Medina, P; Favre, G; Poirot, M; Silvente-Poirot, S	1

Other Studies

1 other study(ies) available for ici 164384 and san 58035

Article	Year
The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1 Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Estradiol; Humans; Models, Molecular; Organosilicon Compounds; Polyunsaturated Alkamides; Receptors, Estrogen; Sterol O-Acyltransferase; Transcription, Genetic	2006

Article

Year

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.

The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1

Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Estradiol; Humans; Models, Molecular; Organosilicon Compounds; Polyunsaturated Alkamides; Receptors, Estrogen; Sterol O-Acyltransferase; Transcription, Genetic

2006